Results 181 to 190 of about 36,083 (204)

DPP-4 inhibitors and risk of heart failure EXAMINEd

Lancet, The, 2015
Eberhard Standl, Oliver Schnell
exaly  

Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4)

Best Practice and Research in Clinical Endocrinology and Metabolism, 2009
Baptist Gallwitz
exaly  

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer

Ca-A Cancer Journal for Clinicians, 2005
Ruth M O'regan
exaly  

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Lancet, The, 2006
Daniel J Drucker, Michael A Nauck
exaly  

Synthesis of a DPP-4 Inhibitor

Synfacts, 2020
openaire   +1 more source

Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review

Clinical Therapeutics, 2012
Vanita R Aroda, Jenny Han, Tamara Darsow
exaly  

[DPP-4 inhibitor (incretin enhancer)].

Nihon rinsho. Japanese journal of clinical medicine, 2012
Jun-Ichiro, Miyagawa, Mitsuyoshi, Namba
openaire   +1 more source

Worsening Heart Failure During the Use of DPP-4 Inhibitors

JACC: Heart Failure, 2018
Milton Packer
exaly  

The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect

International Journal of Environmental Research and Public Health, 2019
Konstantinos Makrilakis
exaly  

Trough DPP-4 Inhibition Differs between the Approved DPP-4 Inhibitors

MD Conference Express, 2013
openaire   +1 more source